Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422267A Processes for the preparation of thiazolidinedione derivatives and intermediates
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422259A Crystalline pharmaceutical
06/04/2003CN1422257A Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
06/04/2003CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
06/04/2003CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422252A Chemokine receptor antagonists
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method
06/04/2003CN1422164A Preparations for preventing bile acid diarrhea
06/04/2003CN1422163A Formulation solubilizing water-insoluble agents and preparation method thereof
06/04/2003CN1422162A Composition and method for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
06/04/2003CN1422161A New combination of a beta blocker and a cholesterol-lowering agent
06/04/2003CN1422159A Remedies
06/04/2003CN1422158A Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1422156A Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
06/04/2003CN1422155A Urease inhibitors
06/04/2003CN1422154A The treatment of respiratory diseases
06/04/2003CN1422153A Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
06/04/2003CN1422152A Combination of organic compound
06/04/2003CN1422151A Pharmaceutical composition comprising fluvastatin
06/04/2003CN1422150A Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
06/04/2003CN1422148A Method for treating dry eye
06/04/2003CN1422146A Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials
06/04/2003CN1422142A Pharmaceutical composition
06/04/2003CN1422125A Composition comprising free amino acids
06/04/2003CN1422122A Method for the fractionation of oil and polar lipid-containing native raw material
06/04/2003CN1421464A Low molecular weight heparine sodium (calcium) and its prepn
06/04/2003CN1421452A Structure and prepn of 2,6-branched oligosaccharide with medicinal application foreground
06/04/2003CN1421451A 9-[2-[[[di (trimethylacetoxyl) methyl phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application
06/04/2003CN1421450A Prepn of 9 [2-[[[di (trimethylacetoxyl) methyl] phosphoros]-methoxy-ethyl] adenine
06/04/2003CN1421449A 9-[2-[[[di (trimethylacetoxyl) methyl] phosphoroso] methoxy]-ethyl] adenine crystal and its prepn and crystal application
06/04/2003CN1421242A Compound red sage capsule for treating cardiac and cerebral vascular diseases and its prepn process
06/04/2003CN1421240A Chinese medicine prepn for treating throat diseases and stomatopathy and its prepn process
06/04/2003CN1421230A Granulation promoting and pus drawing out ointment
06/04/2003CN1421212A Cell growth regulating factor J and its prepn process
06/04/2003CN1421211A Cell growth regulating factor M and its prepn process
06/04/2003CN1421210A Cell growth regulating factor P and its prepn process
06/04/2003CN1421209A Ribose oral liquid
06/04/2003CN1421208A Compound prepn containing alpha-linolic acid, lecithin and ginkgetin
06/04/2003CN1421207A Control released osmotic pump prepn containing ligustrazine phosphate and its prepn process
06/04/2003CN1421206A Medical composition
06/04/2003CN1421205A Compound prepn for promoting growth of hair
06/04/2003CN1421204A Lafutidine injecta and its prepn
06/04/2003CN1421203A New application of berbamine as intracorporeal antitumor drug
06/04/2003CN1421202A Antiviral and antibacterial cantharidinic anhydride medicine composition and its prepn process
06/04/2003CN1421201A Taxane injecta preparation
06/04/2003CN1421199A Veterinary emulsion injection containing parasiticide prepared via micropowder crystallization process
06/04/2003CN1421197A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421196A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421195A Composition containing N-vinyl iminazole polymer of copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421194A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421193A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1110568C Process for producing CTP-rich water solution
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110499C Spiro-quinuclidine derivatives, their preparation and use
06/04/2003CN1110498C Triazolo-pyridzine derivatives as ligands for GABA receptors
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110494C Novel active benzothiepines having inhibitors forileal bile acid transfer and taurocholate salt adsorption
06/04/2003CN1110493C Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/04/2003CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same
06/04/2003CN1110489C Benzisoelenazolone sulfamide derivative, its preparing process and its application in preparing medicines
06/04/2003CN1110488C 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110477C 1,25-dihydroxy-16,22,23-trisdehydro-chdecalciferol derivatives
06/04/2003CN1110327C Novel device for transdermal administration of trimegestone
06/04/2003CN1110313C Medicine for preventing and curing cholesthiasis disease
06/04/2003CN1110309C Medicine for treating psoriasis and its preparing process
06/04/2003CN1110305C Naphthyl-substituted benzimidazole derivatives as anticoagulants
06/04/2003CN1110304C Slow-release medicine composition for oral administration containing nifedipine as active substance
06/04/2003CN1110303C Application of eight precious extract in preparing antiviral medicine
06/04/2003CN1110302C Oxyacid and related compounds for treating skin disease
06/04/2003CN1110299C Triazazole nucleoside aerosol and its preparing method
06/04/2003CN1110298C Dermatologic preparation for external use
06/03/2003USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof
06/03/2003US6573402 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573383 Preparing anhydrous (2R,4S)-4-((3,5-bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester by dissolving in heptanes or water and polar solvent and drying
06/03/2003US6573378 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine having a purity of greater than 95% by weight or it's sodium salt
06/03/2003US6573376 Solvent extraction; plant extracts
06/03/2003US6573367 Derivatives from the class of oleandomycin
06/03/2003US6573302 Topical carrier wherein the topical carrier comprises a member selected from the group comprising lavender oil, myristal myristate, and other preservatives including, hypericum perforatum arnica montana capric acid; and capsaicin and
06/03/2003US6573301 Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
06/03/2003US6573300 Hydroxyurea treatment for spinal muscular atrophy
06/03/2003US6573299 Method and compositions for treatment of the aging eye
1 ... 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 5467 5468 5469 ... 7860